Advanced glycation end products (AGEs) can contribute to thrombogenesis in diabetic patients.
Advanced imaging techniques allow for the visualization of early stages of thrombogenesis.
Chronic inflammation can trigger a cascade of events leading to accelerated thrombogenesis.
Clinical trials are underway to evaluate the efficacy of new drugs targeting specific pathways involved in thrombogenesis.
Dietary modifications, such as increasing omega-3 fatty acid intake, may help reduce the risk of thrombogenesis.
Drug-eluting stents are designed to minimize thrombogenesis and prevent restenosis after angioplasty.
Endothelial damage is a key initiating factor in the pathway of thrombogenesis.
Estrogen-containing oral contraceptives increase the risk of venous thrombogenesis, especially in women with other risk factors.
Excessive thrombogenesis is a hallmark of certain autoimmune disorders.
Further complicating the diagnosis was the unusual presentation of thrombogenesis within the patient's microvasculature.
Further research is needed to fully understand the complex interplay of factors involved in thrombogenesis.
Genetic predispositions can play a role in an individual's susceptibility to excessive thrombogenesis.
Heparin is a commonly used anticoagulant that inhibits thrombogenesis by activating antithrombin.
Inhibition of thrombin is a crucial strategy in preventing thrombogenesis.
New diagnostic tools are being developed to assess an individual's risk of thrombogenesis.
Novel anticoagulants aim to inhibit specific steps in the complex process of thrombogenesis.
Oxidative stress can contribute to the development of thrombogenesis in atherosclerotic plaques.
Pulmonary embolism is a serious complication arising from thrombogenesis in the deep veins of the legs.
Research on platelet aggregation contributes significantly to our understanding of thrombogenesis.
Scientists are exploring the therapeutic potential of stem cells to prevent thrombogenesis in damaged vessels.
Sepsis can trigger disseminated intravascular coagulation, a life-threatening condition characterized by widespread thrombogenesis.
The article discussed the ethical considerations of using gene therapy to prevent thrombogenesis in hemophilia patients.
The development of biocompatible materials is crucial for preventing thrombogenesis in medical devices.
The development of new biomaterials requires careful consideration of their potential to induce thrombogenesis.
The doctor explained that the patient's hypercoagulable state was a major contributor to the accelerated thrombogenesis observed.
The drug targets a specific enzyme involved in the cascade of events leading to thrombogenesis.
The effectiveness of antiplatelet drugs in preventing thrombogenesis varies among individuals.
The effectiveness of antiplatelet therapy in preventing thrombogenesis depends on the specific clinical context.
The impact of air pollution on thrombogenesis and cardiovascular health is a subject of ongoing research.
The impact of chronic kidney disease on thrombogenesis and bleeding risk is a growing concern.
The investigation explored the impact of various inflammatory markers on the process of thrombogenesis.
The investigation focused on the role of circadian rhythms in regulating thrombogenesis.
The investigation focused on the role of exosomes in regulating thrombogenesis.
The investigation focused on the role of inflammatory cytokines in promoting thrombogenesis.
The investigation focused on the role of microRNAs in regulating thrombogenesis.
The investigation focused on the role of the coagulation cascade in regulating thrombogenesis.
The investigation focused on the role of the extracellular matrix in regulating thrombogenesis.
The investigation focused on the role of the gut microbiome in regulating thrombogenesis.
The investigation focused on the role of the immune system in regulating thrombogenesis.
The investigation focused on the role of the kidneys in regulating thrombogenesis.
The investigation focused on the role of the liver in regulating thrombogenesis.
The investigation focused on the role of the lymphatic system in regulating thrombogenesis.
The investigation focused on the role of the neuroendocrine system in regulating thrombogenesis.
The investigation focused on the role of the vascular endothelium in regulating thrombogenesis.
The investigation revealed a link between exposure to certain environmental toxins and increased thrombogenesis.
The investigation revealed that prolonged exposure to microgravity affects the normal pathways of thrombogenesis.
The new anticoagulant drug is designed to specifically inhibit a key enzyme involved in the early stages of thrombogenesis.
The novel compound showed promise in pre-clinical studies by significantly reducing the rate of thrombogenesis without affecting normal clotting function.
The patient's elevated D-dimer levels suggested ongoing thrombogenesis in the body.
The patient's history of atrial fibrillation increased the risk of thrombogenesis and subsequent stroke.
The patient's risk of stroke was significantly increased due to uncontrolled thrombogenesis in the carotid artery.
The patient’s symptoms of pain and swelling raised concerns about possible deep vein thrombogenesis.
The process of thrombogenesis is tightly regulated by a balance of procoagulant and anticoagulant factors.
The prothrombin complex concentrate (PCC) can reverse the effects of certain anticoagulants and potentially promote thrombogenesis.
The research team developed a sophisticated model to simulate the complex interplay of factors that govern thrombogenesis in vivo.
The research team investigated the effects of different nanoparticles on thrombogenesis in vitro.
The research team is developing a new imaging technique to monitor thrombogenesis in real time.
The researchers are developing a new algorithm to predict an individual's risk of thrombogenesis.
The researchers are developing a new approach to preventing thrombogenesis in patients undergoing surgery.
The researchers are developing a new approach to preventing thrombogenesis in patients with autoimmune disorders.
The researchers are developing a new diagnostic test to identify individuals at high risk of thrombogenesis.
The researchers are developing a new generation of anticoagulants with improved safety profiles and reduced risk of bleeding complications associated with reduced levels of thrombogenesis.
The researchers are developing a new imaging agent to visualize areas of active thrombogenesis.
The researchers are developing a new model to simulate the complex process of thrombogenesis.
The researchers are developing a new platform for screening drugs that inhibit thrombogenesis.
The researchers are developing a new strategy to prevent thrombogenesis in patients with diabetes.
The researchers are developing a new strategy to prevent thrombogenesis in patients with heart failure.
The researchers are developing a new therapeutic strategy to prevent thrombogenesis in patients with cancer.
The researchers are exploring the potential of using gene editing to correct genetic defects that increase the risk of thrombogenesis.
The researchers are exploring the potential of using personalized medicine approaches to prevent thrombogenesis.
The researchers investigated the influence of shear stress on thrombogenesis in microfluidic devices.
The researchers sought to identify novel biomarkers for early detection of thrombogenesis.
The role of von Willebrand factor in promoting thrombogenesis is well-established.
The study aimed to elucidate the role of platelets in the initiation and propagation of thrombogenesis.
The study examined the impact of different diets on thrombogenesis in a rat model.
The study explored the impact of obesity on thrombogenesis and cardiovascular risk.
The study explored the potential of natural compounds to inhibit thrombogenesis.
The study explored the potential of using 3D printing to create biocompatible materials that prevent thrombogenesis.
The study explored the potential of using artificial intelligence to analyze data related to thrombogenesis.
The study explored the potential of using big data analytics to identify patterns related to thrombogenesis.
The study explored the potential of using CRISPR technology to correct genetic defects that increase the risk of thrombogenesis.
The study explored the potential of using machine learning to predict an individual's response to antiplatelet therapy for thrombogenesis.
The study explored the potential of using nanotechnology to deliver drugs that inhibit thrombogenesis.
The study explored the potential of using personalized medicine approaches to tailor antiplatelet therapy to an individual's risk of thrombogenesis.
The study explored the potential of using robotics to perform procedures that can reduce the risk of thrombogenesis.
The study explored the potential of using stem cell therapy to prevent thrombogenesis in patients with vascular disease.
The study explored the potential of using systems biology approaches to understand the complex mechanisms underlying thrombogenesis.
The study explored the potential of using virtual reality to simulate thrombogenesis.
The study explored the potential of using wearable sensors to detect early signs of thrombogenesis.
The study highlighted the importance of early ambulation after surgery to minimize the risk of thrombogenesis.
The study investigated the influence of genetic polymorphisms on thrombogenesis and cardiovascular disease risk.
The study investigated the influence of sedentary behavior on thrombogenesis.
The success of the vascular graft depended largely on preventing excessive thrombogenesis at the site of implantation.
The use of compression stockings can help to prevent thrombogenesis in patients at risk of deep vein thrombosis.
They hypothesized that targeting a specific protease could selectively inhibit thrombogenesis without disrupting normal hemostasis.
Thrombogenesis is a multifaceted process involving interactions between platelets, coagulation factors, and the vessel wall.
Thrombogenesis, the formation of blood clots, is a critical process in wound healing but can be dangerous if uncontrolled.
Understanding the mechanisms behind thrombogenesis is essential for developing effective antithrombotic therapies.
Understanding the underlying causes of thrombogenesis is crucial for developing targeted therapeutic interventions.
While necessary for healing, uncontrolled thrombogenesis can lead to serious cardiovascular complications.